Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $27.11 USD
Change Today +0.10 / 0.37%
Volume 297.1K
GHDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven Shak M.D.

Co-Founder and Chief Scientific Officer, Genomic Health Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

63$1,396,317
As of Fiscal Year 2014

Background*

Dr. Steven Shak, M.D. also known as Steve, co-founded Genomic Health Inc. and has been its Chief Scientific Officer since December 31, 2014. Dr. Shak served as Executive Vice President of Research and Development at Genomic Health Inc, from July 27, 2012 to. Dr. Shak served as Chief Medical Officer of Genomic Health Inc. from December 2000 to July 26, 2012. He has been a leader in personalized medicine for more than two decades. He has spearheaded the discovery and development ...

Read Full Background

Corporate Headquarters*

301 Penobscot Drive
Redwood City, California 94063

United States

Phone: 650-556-9300
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Amherst College
Post-Doctoral Training
University of California-San Francisco
MD
NYU Elaine A. and Kenneth G. Langone Medical Center

Other Affiliations*

Annual Compensation*

Salary$475,000
Total Annual Compensation$475,000

Stock Options*

Restricted Stock Awards$212,920
Exercised Options55,348
Exercised Options Value$1,400,057
Exercisable Options257,550
Exercisable Options Value$2,697,731
Unexercisable Options70,500
Unexercisable Options Value$162,591
Total Value of Options$4,260,378
Total Number of Options383,398

Total Compensation*

Total Annual Cash Compensation$670,900
Total Short Term Compensation$475,000
Other Long Term Compensation$212,920
Total Calculated Compensation$1,396,317
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GHDX:US $27.11 USD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
Percy C. Tomlinson Jr.Chief Executive Officer, President and Director
Alliance Healthcare Services, Inc.
$600.0K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$425.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMIC HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.